NSAIDs activate PTEN and other phosphatases in human colon cancer cells: novel mechanism for chemopreventive action of NSAIDs

Biochemical and Biophysical Research Communications
Eric C ChuAndrzej S Tarnawski

Abstract

Studies on chemoprevention of colorectal cancer have generated increasing interest. The mechanisms involved in NSAIDs chemopreventive action are not fully elucidated. In this study, we examined in human colon cancer cells the effect of indomethacin and NS-398 (a pre-clinical selective COX-2 inhibitor) on expression of 96 genes of the EGF/PDGF signaling pathways essential for cell proliferation, migration, and survival. We found that indomethacin and NS-398 treatment significantly upregulated expression of the tumor suppressor gene, PTEN, the MAP kinase phosphatase-3, MKP-3, and the protein tyrosine phosphatase, SHP2. Additionally, NS-398 treatment increased expression of apoptotic genes such as BAD, STAT1, and CASP3. These results suggest that as a consequence of increased expression of phosphatases such as PTEN and the resulting dephosphorylation of kinases, NSAIDs can negatively regulate the EGF/PDGF pathways in colon cancer cells-a novel mechanism for NSAIDs' chemopreventive actions.

References

Dec 15, 1991·The New England Journal of Medicine·M J ThunC W Heath
Sep 7, 1995·The New England Journal of Medicine·E GiovannucciF E Speizer
Aug 15, 1994·Annals of Internal Medicine·E GiovannucciW C Willett
May 6, 1993·The New England Journal of Medicine·F M GiardielloG J Offerhaus
Aug 19, 1997·Proceedings of the National Academy of Sciences of the United States of America·M P MyersN K Tonks
Aug 1, 1997·Human Molecular Genetics·M R NelenH Kremer
Oct 28, 1998·Genes, Chromosomes & Cancer·N HalachmiD Sidransky
Oct 30, 1998·Oncogene·E ForgacsJ D Minna
Dec 1, 1998·Journal of Medical Genetics·D J MarshC Eng
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·X WuC L Sawyers
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·L C Cantley, B G Neel
May 11, 1999·European Journal of Human Genetics : EJHG·M R NelenG W Padberg
Jun 11, 1999·Japanese Journal of Cancer Research : Gann·N KawamuraM Emi
Jan 11, 2000·International Journal of Cancer. Journal International Du Cancer·M SaitoT Tanaka
Jun 14, 2000·International Journal of Molecular Medicine·Y YokoyamaT Tamaya
Jun 24, 2000·Molecular and Cellular Biology·F VazquezW R Sellers
Jun 30, 2000·The New England Journal of Medicine·G SteinbachG Kelloff
Sep 9, 2000·Journal of Medical Genetics·J T CelebiM Peacocke
Jan 10, 2001·International Journal of Cancer. Journal International Du Cancer·H B SalvesenS Das
Aug 16, 2001·Journal of the National Cancer Institute·J S SmithR B Jenkins
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Quan DuAnnika Lindblom
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
Mar 7, 2003·The New England Journal of Medicine·Robert S SandlerRichard Schilsky
Nov 12, 2003·The Journal of Pharmacology and Experimental Therapeutics·Tao ZhangBruce M Boman
Feb 6, 2004·Annals of Internal Medicine·Andrew T ChanCharles S Fuchs
Jun 24, 2010·Cancer Prevention Research·Imad ShureiqiScott M Lippman

❮ Previous
Next ❯

Citations

Dec 13, 2006·Breast Cancer Research : BCR·Gargi D BasuPinku Mukherjee
May 3, 2014·Nigerian Medical Journal : Journal of the Nigeria Medical Association·Imran Haruna Abdulkareem
Jun 27, 2013·Nigerian Medical Journal : Journal of the Nigeria Medical Association·Imran Haruna Abdulkareem, Maria Blair
Jun 27, 2013·Nigerian Medical Journal : Journal of the Nigeria Medical Association·Imran Haruna Abdulkareem, Maria Blair
May 9, 2012·Experimental and Molecular Pathology·Manpreet Kaur Saini, Sankar Nath Sanyal
Jul 19, 2011·Prostaglandins & Other Lipid Mediators·Hsin-Hsiung TaiMin Tong
Apr 25, 2006·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Mark A ScheperTimothy F Meiller
Mar 24, 2005·World Journal of Gastroenterology : WJG·Mei-Hua Xu, Gui-Ying Zhang
Jun 12, 2012·Pharmaceutical Development and Technology·Yellela S R Krishnaiah, Mansoor A Khan
Mar 31, 2015·The Cochrane Database of Systematic Reviews·Nondumiso Mkontwana, Natalia Novikova

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis